Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides
about
An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4Vasohibin as an endothelium-derived negative feedback regulator of angiogenesisA macrophage mRNA selectively induced by gamma-interferon encodes a member of the platelet factor 4 family of cytokinesCloning and characterization of a novel murine beta chemokine receptor, D6. Comparison to three other related macrophage inflammatory protein-1alpha receptors, CCR-1, CCR-3, and CCR-5Platelet factor 4 enhances the binding of oxidized low-density lipoprotein to vascular wall cellsActin is a binding protein for angiogeninNuclear translocation of angiogenin in proliferating endothelial cells is essential to its angiogenic activityEosinophil cationic granule proteins impair thrombomodulin function. A potential mechanism for thromboembolism in hypereosinophilic heart diseasePeptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activityHuman Mig chemokine: biochemical and functional characterizationHuman interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivoAntiangiogenic gene therapy of cancer: recent developmentsDiscovery of novel biomarkers by microarray analysis of peripheral blood mononuclear cell gene expression in benzene-exposed workers.The Role of Chemokines in Fibrotic Wound HealingAnti-angiogenic gene therapy in the treatment of malignant gliomasRegulation of Chemokine Activity - A Focus on the Role of Dipeptidyl Peptidase IV/CD26Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165Roles of platelet factor 4 in hematopoiesis and angiogenesisApplication of proteomics to soft tissue sarcomasThe Fibrin Matrix Regulates Angiogenic Responses within the Hemostatic Microenvironment through Biochemical ControlSemaphorin 3E initiates antiangiogenic signaling through plexin D1 by regulating Arf6 and R-Ras.Chemokines as mediators of tumor angiogenesis and neovascularizationAngiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3.CXC chemokines in cancer angiogenesis and metastasesChemokines as mediators of neovascularizationThe CXC-chemokine CXCL4 interacts with integrins implicated in angiogenesis.Platelet granule secretion continuously prevents intratumor hemorrhage.Inhibition of choroidal neovascularization by intravenous injection of adenoviral vectors expressing secretable endostatin.Mouse model of angiogenesisEvidence for a granule targeting sequence within platelet factor 4.Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhageMechanism of platelet factor 4 (PF4) deficiency with RUNX1 haplodeficiency: RUNX1 is a transcriptional regulator of PF4.Heparin-induced thrombocytopenia in the pediatric population: a review of current literatureAtomic features of an autoantigen in heparin-induced thrombocytopenia (HIT).Platelet factor 4 is produced by subsets of myeloid cells in premetastatic lung and inhibits tumor metastasisThe role of platelets in tumour growth.Angiogenesis in cancer: the role of endothelin-1.Structure, function and tissue forms of the C-terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin.Platelet factor-4 and its p17-70 peptide inhibit myeloma proliferation and angiogenesis in vivoCurrent status of antiangiogenic factors.
P2860
Q24303828-9C4477E2-429C-4BF7-B4E5-8E072D78FDB7Q24306415-F29FA4DB-5448-4253-BA4C-39DC84DB20ECQ24315971-56366DE7-7071-47AB-BF2E-B40A1A3FAF35Q24318708-A24E931E-AD72-414E-9229-121B6BE29C5FQ24323257-073B3F25-E84E-48D1-B878-CB4BB5BDB8D0Q24337648-51F3469E-D21F-4EF1-A165-A51853C8A7B3Q24564658-7C952CFE-7AE9-4244-8950-CF5AF5DA11A1Q24599265-1E1D7D49-3DA1-433B-B8FE-39D3C2C17D66Q24674570-657FAA55-B1C8-4146-A387-5F50EE4D168BQ24678720-5312F985-0A39-4F1C-9352-4980EF1E48FDQ24678892-625BC842-DAF3-4357-8EFD-9912D92DEBAFQ24803786-8FA67514-8F6B-44CC-BC19-31CD2F86B887Q24813357-D5239EB8-0627-4F33-A380-9FF534DF2E69Q26778686-8A984D9E-D40E-4976-8FF4-33F149362D7DQ26866276-6E31A8F8-81A1-4909-BC25-F14288FDC54EQ28072580-580325B9-9222-4E66-AAFE-80ED38ACB173Q28214421-4B063F9A-CD03-4EDA-AF88-6E4B4D02C788Q28294538-4971EB1D-3458-469D-B06F-00F678698FEEQ28385995-41A041AD-1C40-4573-8642-F2177B5233CEQ28547610-7235A9FB-CCE0-4983-9ABF-9E9B6ECF4906Q28593676-35525D39-8F81-4F22-91D6-92EB17B37A9CQ30427886-B24B352A-0B09-41EB-BB9A-B01F9E32CD55Q30428793-9273467D-578D-458B-8960-E4F37A003C06Q30432791-D4D3B93B-55C5-4F8F-82D6-A188CD90E8CEQ30438032-B3870208-A93B-4BB6-954B-E554F3F33582Q30441368-74F36080-1344-44D3-8587-0DE69AEB4608Q30483704-9F217814-9D30-444C-853E-AD7E88E43306Q30686422-7DC6CB80-13B4-4AFA-B18D-D79E7E72BFC4Q32061166-0CA6B2C0-6473-44D9-8074-543E5551E8D3Q33217394-7348F47D-FA1A-4076-A5FF-001122A732D1Q33369958-4E0A9236-7771-4B89-8CAA-A07099D64C29Q33393133-B12899AB-3EC9-49A1-9837-9FF33625A136Q33404178-5CC4EE1F-9169-476C-8DEE-2F59DD92F050Q33430677-ED65A11E-5A98-4B58-BF7F-23384E0AE11FQ33709419-FCAB0035-F369-4060-B75E-46E668F5E2A4Q33803558-CBE9B4D1-7521-43E0-866C-26ED8696CF0FQ33822741-001710B8-0889-4EE0-A156-912F40728B38Q33889173-76EDB82A-662B-4489-B65E-D8E7265A409EQ33938595-4A5F0DF0-9ADB-4D2A-B1EF-DB6692F2E49FQ33962049-FB7F7345-F012-46AF-A4BC-5931ECD6C441
P2860
Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides
description
1990 nî lūn-bûn
@nan
1990 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides
@ast
Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides
@en
Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides
@en-gb
Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides
@nl
type
label
Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides
@ast
Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides
@en
Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides
@en-gb
Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides
@nl
prefLabel
Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides
@ast
Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides
@en
Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides
@en-gb
Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides
@nl
P2093
P3181
P356
P1433
P1476
Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides
@en
P2093
A L Donner
H F Carson
R J Sharpe
T E Maione
P3181
P356
10.1126/SCIENCE.1688470
P407
P577
1990-01-05T00:00:00Z